Navigation Links
Cocoon Biotech Announces CEO, Dr. Ailis Tweed-Kent, Named to Boston Business Journal's "2017 Women to Watch in Science and Technology" List
Date:2/16/2017

BOSTON, Feb. 16, 2017 /PRNewswire/ -- Cocoon Biotech, Inc., a biotechnology company focused on the development of osteoarthritis and other drug-delivery therapies based on its silk protein technology, has announced that Cocoon Founder and CEO, Ailis Tweed-Kent, M.D., has been named by the Boston Business Journal as one of the "2017 Women to Watch in Science and Technology" winners.

The journal has named Dr. Tweed-Kent as one of the ten recipients and according to the journal, "recognizes New England's female technology and business leaders; the innovators who are helping to build new companies and drive established tech companies in new directions." The honorees will be recognized today at the 14th Annual Women to Watch Awards Breakfast in Boston.

"I am honored, humbled and thankful to be named as a leader in this field of incredibly bright women who are each committed to making important advances in their respective areas of science and technology," stated Dr. Tweed-Kent. "My hope is that the important work that we are doing at Cocoon Biotech will ultimately improve the lives of thousands of patients worldwide who are suffering from osteoarthritis."

About Cocoon Biotech, Inc.
Cocoon Biotech was founded in 2013 to bring treatments for arthritis and other debilitating diseases to market. Cocoon Biotech's platform technology is a biocompatible silk protein that can be loaded with small molecule or protein therapeutics and injected into joints to provide effective, long-lasting pain relief and potentially delay the progression of disease. This platform will leverage several unique properties of the silk protein fibroin, including strength and biocompatibility. For more information, please visit www.cocoonbiotech.com.

Contact:
Jennifer Williams
Cook Williams Communications, Inc.
650-315-3538
jennifer@cwcomm.org

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cocoon-biotech-announces-ceo-dr-ailis-tweed-kent-named-to-boston-business-journals-2017-women-to-watch-in-science-and-technology-list-300408629.html


'/>"/>
SOURCE Cocoon Biotech, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. FinancialBuzz.com: Developments in the Biotechnology Market
2. White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
3. Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech
4. Technical Reports on Biotech Stocks -- Progenics Pharma, Intrexon, Synthetics Biologics, and 22nd Century
5. The Biotech Market Grows as Demand for New Therapeutics Increases
6. Biotech Stocks Under Scanner -- Mast Therapeutics, MannKind, Celgene, and Opko Health
7. Diplomat Completes Acquisition of Affinity Biotech
8. Global Nanobiotechnology Applications, Markets and Companies Report 2017-2020 & 2025: Profiles of 250+ Companies with Their 180 Collaborations - Research and Markets
9. Global Smart Inhalers Market Analysis & Trends 2017-2025: Recent R&D Programs by Top Players in Pharmaceutical and Biotechnological Industries - Research and Markets
10. Research Reports Initiation on Biotech Stocks -- Portola Pharma, Tesaro, Sangamo Therapeutics, and Cerus
11. FinancialBuzz.com: Advances in Technology Applied in the Biotech Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence ... advanced Parkinson,s, according to a study released today that will ... Annual Meeting in Boston , April ... to the treatment of Parkinson,s disease, the oral drug levodopa ... life and longevity. But as the disease progresses, the effects ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... HR decision-makers are preparing for how his administration could impact the employee benefits ... into what changes are most likely to make it through Congress. His discussion ...
(Date:4/25/2017)... NV (PRWEB) , ... April 25, 2017 , ... ... now choose a modern procedure that achieves results in a fraction of the ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment ...
(Date:4/25/2017)... Minneapolis MN (PRWEB) , ... April 25, 2017 , ... ... patients and recreational users to dispensaries and head shops –can’t help but be heartened ... loathing for the tell-tale cannabis odor aptly described as “skunk smell.” At last ...
(Date:4/25/2017)... ... 2017 , ... There is no better place in South Florida to undergo ... the May issue of Consumer Reports focused on heart health. , The magazine ... and after coronary bypass and aortic valve replacement procedures. , Consumer Reports rated ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
Breaking Medicine News(10 mins):